Skip to content

CDR

Walgreens uses intelligent automation in HR

Walgreens uses intelligent automation in HR

Walgreens worked with IBM and automation specialist Blue Prism to implement digital workforce capabilities for its human resources function. IBM said Walgreens is now using robotic processing automation (RPA) software from Austin, Texas-based Blue Prism to support its HR function.

Industry mourns Arbor Drugs founder Eugene Applebaum

Industry mourns Arbor Drugs founder Eugene Applebaum

Eugene Applebaum, the founder of Michigan pharmacy chain Arbor Drugs, passed away at his home here on Friday at age 81. After earning a pharmacy degree at Wayne State University, Applebaum entered the drug store business in 1963 with the opening of one store, Civic Drugs, in Dearborn, Mich. In 1974,

Police probe suspicious death of Apotex founder

Police probe suspicious death of Apotex founder

Police are investigating the deaths of Barry Sherman, the founder of Apotex Inc., and his wife Honey, whose bodies were found at their North York, Ontario, home on Friday. As of Sunday, autopsies on Sherman and his wife were pending, published reports said.

Analyst: No ‘kneejerk reaction’ from WBA

Analyst: No ‘kneejerk reaction’ from WBA

A CVS-Aetna merger or not, Walgreens Boots Alliance is zeroed in and making headway on its strategic game plan, according to Jefferies analyst Brian Tanquilut. Following a visit to WBA’s headquarters in Deerfield, Ill.

American Greetings debuts Wacky Wonderland cards

American Greetings debuts Wacky Wonderland cards

American Greetings is looking to get some laughs this holiday season. The greeting card maker this week introduced American Greetings Wacky Wonderland Christmas cards, which the company said are designed to shake up the holiday with irreverent humor.

HDA study gauges specialty drug market

HDA study gauges specialty drug market

In the specialty pharmaceutical arena, products in the autoimmune/immune and ophthalmology categories stand to grow in importance over the next 12 months, followed by oncology, central nervous system and inflammatory drugs, according to the HDA Research Foundation.